Phenylbiguanide

Phenylbiguanide (PBG) is a 5-HT3 agonist used to study the role of 5-HT3 receptors in the central nervous system.[1] It has been found to trigger dopamine release in the nucleus accumbens of rats.[2]

Phenylbiguanide
Legal status
Legal status
  • UN: Unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.002.726
Chemical and physical data
FormulaC8H11N5
Molar mass177.211 g·mol−1
3D model (JSmol)
Melting point135–142 °C (275–288 °F)

Derivatives

  • Phenylbiguanide is used to make amanozine and benfosformin.

References

  1. Higgins, GA; Joharchi, N; Sellers, EM (1993), "Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.", J Pharmacol Exp Ther, Journal of Pharmacology and Experimental Therapeutics, 264: 1440–9, PMID 8450478
  2. Chen, JP; van Praag, HM; Gardner, EL (1991), "Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.", Brain Res, Brain Research., 543 (2): 354–7, doi:10.1016/0006-8993(91)90050-6, PMID 1711914


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.